Hung‐Ming Wang

7.0k citations
92 papers · 5.3k · 2 hit papers · h-index 31

Impact in

    • Head and Neck Cancer Studies
  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Cancer Cells and Metastasis

Papers in

    • Head and Neck Cancer Studies 25
    • Cancer Cells and Metastasis 7
    • Inflammatory Biomarkers in Disease Prognosis 6
    • Cancer-related Molecular Pathways 5
    • Colorectal Cancer Treatments and Studies 4

Hung‐Ming Wang

90 papers receiving 5.2k citations

Hung‐Ming Wang's Hit Papers

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial 2024 · 134 citations
1340+2+4Years since publication50010001.5k2.0k

Peers

Hung‐Ming Wang
Comparison fields: 5 of 131
  • Otorhinolaryngology 1.8k
  • Oncology 1.9k
  • Cancer Research 494
  • Pulmonary and Respiratory Medicine 706
  • Immunology 411
Replace Jonathan Daniel Schoenfeld with:
Jonathan Daniel Schoenfeld United States
Renata Ferrarotto United States
Joseph Tung‐Chieh Chang Taiwan
Chaosu Hu China
Hai-Qiang Mai China
Guan‐Qun Zhou China
Yan‐Ping Mao China
Karijn P.M. Suijkerbuijk Netherlands
Ruta Gupta Australia
Wai Tong Ng China
Hung‐Ming Wang relative to Jonathan Daniel Schoenfeld United States Jonathan Daniel Schoenfeld's profile →
Citations per field
00.5×1.5×1.8×
Jonathan Daniel Schoenfeld · 1×
Citations per year

Countries citing papers authored by Hung‐Ming Wang

Since Specialization
Citations

This map shows the geographic impact of Hung‐Ming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung‐Ming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung‐Ming Wang more than expected).

Fields of papers citing papers by Hung‐Ming Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hung‐Ming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung‐Ming Wang. The network helps show where Hung‐Ming Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Hung‐Ming Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hung‐Ming Wang Line = papers co-authored together Hung‐Ming Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Hit paper breakdown →
20192460
2 2006210
3 2004148
4
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
Hit paper breakdown →
2024134
5 2006122
6 2008113
7 2000112
8 201293
9 200588
10 201483
11 201376
12 201274
13 200968
14 199561
15 201260
16 201258
17 200756
18 200554
19 201453
20 200652

About Hung‐Ming Wang

Hung‐Ming Wang is a scholar working on Otorhinolaryngology, Oncology, Computer Vision and Pattern Recognition, Signal Processing and Pulmonary and Respiratory Medicine, having authored 92 papers that have together received 5.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (25 papers), Advanced Vision and Imaging (8 papers), Cancer Cells and Metastasis (7 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers), Video Coding and Compression Technologies (6 papers), Cancer-related Molecular Pathways (5 papers), Palliative Care and End-of-Life Issues (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Otorhinolaryngology (1.8k citations), Oncology (1.9k citations), Cancer Research (494 citations), Pulmonary and Respiratory Medicine (706 citations) and Immunology (411 citations). Hung‐Ming Wang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Chun‐Ta Liao, Shiang‐Fu Huang, Shu‐Hang Ng, Chung‐Jan Kang, Jen‐Shi Chen, Tzu‐Chen Yen, Sheng-Chieh Chan, I‐How Chen, Joseph Tung‐Chieh Chang and Ling‐Ling Hsieh. Their work appears in journals such as Cancers, Anti-Cancer Drugs, Oral Oncology, Journal of Pain and Symptom Management and Supportive Care in Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact